Duguet et al.
m), 7.12-7.40 (5H, m); 13C NMR (293 K, two rotamers observed)
δ 23.7 (2 × CH2), 28.6 (3 × CH3), 32.2 and 32.8 (CH2), 44.1 and
44.4 (CH2), 51.1 and 51.5 (CH2), 53.9 and 54.0 (2 × CH2), 54.4
and 55.6 (CH), 60.2 and 60.4 (CH), 63.5 and 63.8 (CH2), 79.2 (C),
127.5, 128.5 (5 × CH), 142.6 and 142.9 (C), 154.8 (C); IR (neat)
ν 3293 (NH), 3063, 2974, 2876, 2802, 2246, 1682 (CdO), 1602,
N-Methyl-3-(S)-(1-(R)-r-naphthylethyl)aminopyrrolidine 15.
Reduction of N-(tert-butoxycarbonyl)-3-(S)-(1-(R)-R-naphthylethy-
l)aminopyrrolidine 9 (0.68 g, 2.00 mmol) following the above
general procedure gave 15 (0.41 g, 80%) as an orange oil: 1H NMR
δ 1.48 (3H, d, J ) 6.8), 1.64-1.77 (1H, m), 1.97-2.19 (1H, m),
2.19-2.48 (2H, m), 2.29 (3H, s), 2.48-2.74 (2H, m), 3.17-3.33
(1H, m), 4.68 (1H, q, J ) 6.8), 7.37-7.57 (3H, m), 7.67 (1H, d, J
) 6.8), 7.74 (1H, d, J ) 8.3), 7.81-7.93 (1H, m), 8.07-8.30 (1H,
m); 13C NMR δ 24.1 (CH3), 33.1 (CH2), 42.4 (CH3), 51.5 (CH),
55.5 (CH2), 55.6 (CH), 63.6 (CH2), 123.0, 123.3, 125.3 (3 × CH),
125.8 (2 × CH), 127.2, 129.1 (2 × CH), 131.4, 134.0, 141.3 (3 ×
C) (diastereomer 3R,8R, visible peaks 24.2, 33.5, 51.8, 55.3, 55.4,
122.9, 123.0); IR (neat) ν 3304 (NH), 3047, 2960, 2863, 2833,
1477, 1454, 1413, 1366, 1255, 1167, 1125; [R]20 -67.5 (c 0.54,
D
CHCl3); CIMS (200 eV, t-BuH) m/z 360 (MH+, 100), 323 (13),
302 (MH+ - t-Bu, 7), 286 (MH+ - Ot-Bu, 7), 275 (MH+
-
C5H10N, 15), 219 (MH+ - C5H10N - t-Bu, 12), 174 (C12H16N, 6),
154 (12), 84 (C5H10N, 39); HRMS (m/z) [MH+] C21H34N3O2
requires 360.2659, found 360.2659.
N-(tert-Butoxycarbonyl)-3-(S)-(1-(S)-phenyl-2-N’-piperidinyl-
ethyl)aminopyrrolidine 14a. Carbamate 14a was obtained using
N-(tert-butoxycarbonyl)-3-(R)-hydroxypyrrolidine 2 (0.94 g, 5.00
mmol, 1.0 equiv) with (S)-1-phenyl-2-(piperidin-1-yl)ethanamine
8a (1.53 g, 7.50 mmol, 1.5 equiv), and following the above general
procedure. Purification of the residue by column chromatography
(EtOAc/acetone 95:5) gave 14a (0.98 g, 52%) as a pale yellow
oil: 1H NMR δ 1.24-1.70 (17H, 2m), 1.71-2.09 (1H, m),
2.10-2.74 (6H, 3m), 2.80-3.65 (5H, 3m), 3.67-3.88 (1H, m),
7.03-7.42 (5H, m); 13C NMR (293 K, two rotamers observed) δ
24.5 (CH2), 26.2 (2 × CH2), 28.6 (3 × CH3), 30.9 and 31.6 (CH2),
44.2 and 44.5 (CH2), 51.9 and 52.5 (CH2), 54.4 and 54.6 (2 ×
CH2), 55.2 and 55.4 (CH), 57.9 and 58.2 (CH), 66.3 (CH2), 79.1
and 79.2 (C), 127.4, 127.5, 128.5 (5 × CH), 142.9 (C), 154.7 and
154.8 (C); IR (neat) ν 3291 (NH), 3062, 3010, 2976, 2937, 2805,
21
2775, 1594, 1509, 1477, 1447, 1393, 1367, 1232, 1174, 1136; [R]D
+38.4 (c 0.87, CHCl3); EIMS (70 eV) m/z 254 (M+, <1), 170
(C12H12N, 13), 155 (C12H11, 25), 141 (3), 127 (C10H7 and C7H15N2,
8), 113 (5), 96 (14), 83 (M+ - C12H12N, 28), 58 (100).
N-Methyl-3-(S)-(1-(R)-ꢀ-naphthylethyl)aminopyrrolidine 16a.
Reduction of N-(tert-butoxycarbonyl)-3-(S)-(1-(R)-ꢀ-naphthylethyl)-
aminopyrrolidine 10a (0.68 g, 2.00 mmol) following the above
general procedure gave 16a (0.44 g, 87%) as a pale yellow oil: 1H
NMR δ 1.42 (3H, d, J ) 6.4), 1.46-1.95 (2H, m), 1.95-2.14 (1H,
m), 2.14-2.43 (2H, m), 2.27 (3H, s), 2.43-2.52 (1H, m), 2.52-2.71
(1H, m), 3.08-3.26 (1H, m), 3.96 (1H, q, J ) 6.4), 7.35-7.60
(3H, m), 7.73 (1H, s), 7.74-7.90 (3H, m); 13C NMR δ 24.5 (CH3),
32.7 (CH2), 42.2 (CH3), 55.2 (CH2), 55.4 (CH), 56.3 (CH), 63.5
(CH2), 125.0, 125.3, 125.4, 125.9, 127.6, 127.7, 128.1 (7 × CH),
132.8, 133.4, 143.0 (3 × C) (diastereomer 3R,8R, visible peaks
24.6, 33.4, 42.3, 55.19, 55.22, 56.7, 62.4, 124.9, 125.3, 125.4, 125.9,
127.6, 127.7, 128.2, 132.8, 133.4, 142.9); IR (neat) ν 3307 (NH),
2399, 1681 (CdO), 1602, 1476, 1453, 1414, 1365; [R]20 +57.1
D
(c 0.64, CHCl3); HRMS (m/z) [MH+] C22H36N3O2 requires 374.2816,
found 374.2826.
3054, 2962, 2838, 2783, 2359, 2189, 1600, 1506, 1477, 1448; [R]20
D
N-(tert-Butoxycarbonyl)-3-(S)-(1-(R)-phenyl-2-N’-piperidinyl-
ethyl)aminopyrrolidine 14b. Carbamate 14b was obtained using
N-(tert-butoxycarbonyl)-3-(R)-hydroxypyrrolidine 2 (0.94 g, 5.00
mmol, 1.0 equiv) with (R)-1-phenyl-2-(piperidin-1-yl)ethanamine
8b (1.53 g, 7.50 mmol, 1.5 equiv), and following the above general
procedure. Purification of the residue by column chromatography
(EtOAc/acetone 95:5) gave 14b (1.20 g, 64%) as a pale yellow
oil: 1H NMR δ 1.00-1.68 (17H, 2m), 1.70-1.95 (1H, m),
1.96-2.60 (6H, 2m), 2.81-3.21 (3H, m), 3.22-3.52 (2H, 2m),
3.53-3.85 (1H, m), 6.99-7.42 (5H, m); 13C NMR (293 K, two
rotamers observed) δ 24.6 (CH2), 26.3 (2 × CH2), 28.6 (3 × CH3),
32.3 and 33.0 (CH2), 44.1 and 44.5 (CH2), 51.2 and 51.6 (CH2),
54.5 (2 × CH2), 55.8 (CH), 58.4 (CH), 66.4 (CH2), 79.2 (C), 127.4,
127.5, 127.6, 128.5 (5 × CH), 142.9 and 143.2 (C), 154.8 (C); IR
(neat) ν 3290 (NH), 3061, 2975, 2935, 2854, 2805, 2244, 1686
(CdO), 1602, 1477, 1453, 1408, 1365, 1255, 1166, 1138, 1117;
+58.4 (c 1.02, CHCl3); EIMS (70 eV) m/z 254 (M+, 22), 170
(C12H12N, 100), 155 (C12H11, 46), 127 (C10H7 and C7H15N2, 9), 99
(M+ - C12H11, 56), 85 (M+ - C12H12N, 38), 57 (71).
N-Methyl-3-(S)-(1-(S)-ꢀ-naphthylethyl)aminopyrrolidine 16b.
Reduction of N-(tert-butoxycarbonyl)-3-(S)-(1-(S)-ꢀ-naphthylethyl)-
aminopyrrolidine 10b (0.68 g, 2.00 mmol) following the above
general procedure gave 16b (0.42 g, 83%) as a pale yellow oil: 1H
NMR δ 1.41 (3H, d, J ) 6.8), 1.42-1.59 (1H, m), 1.60-1.93 (1H,
m), 1.95-2.12 (1H, m), 2.12-2.40 (1H, m), 2.32 (3H, s), 2.40-2.52
(1H, m), 2.52-2.72 (2H, m), 3.07-3.26 (1H, m), 3.94 (1H, q, J )
6.8), 7.35-7.58 (3H, m), 7.73 (1H, s), 7.76-7.92 (3H, m); 13C
NMR δ 24.6 (CH3), 33.4 (CH2), 42.3 (CH3), 55.1 (CH2), 55.2 (CH),
56.7 (CH), 62.4 (CH2), 124.9, 125.3, 125.4, 125.9, 127.6, 127.7,
128.2 (7 × CH), 132.8, 133.4, 142.9 (3 × C) (diastereomer 3R,8S,
visible peaks 24.5, 32.7, 42.2, 55.3, 55.4, 56.3, 63.5, 125.0, 125.3,
125.4, 125.9, 127.6, 127.7, 128.1, 132.8, 133.4, 143.0); IR (neat)
ν 3307 (NH), 3054, 2963, 2839, 2783, 2189, 1600, 1506, 1477,
1448; [R]20D -72.1 (c 1.16, CHCl3); EIMS (70 eV) m/z 254 (M+,
14), 170 (C12H12N, 100), 155 (C12H11, 35), 127 (C10H7 and C7H15N2,
10), 99 (M+ - C12H11, 65), 85 (M+ - C12H12N, 31), 57 (73).
N-Methyl-3-(S)-(1-(R)-cyclohexylethyl)aminopyrrolidine 17.
Reduction of N-(tert-butoxycarbonyl)-3-(S)-(1-(R)-cyclohexylethyl)-
aminopyrrolidine 11 (0.59 g, 2.00 mmol) following the above
general procedure gave 17 (0.34 g, 81%) as a yellow-orange oil:
1H NMR δ 0.77-1.37 (7H, m), 0.95 (3H, d, J ) 6.4), 1.42-1.57
(1H, m), 1.57-1.80 (5H, m), 2.00-2.23 (1H, m), 2.23-2.35 (1H,
m), 2.30 (3H, s), 2.35-2.48 (2H, m), 2.48-2.77 (2H, 2m),
3.26-3.47 (1H, m); 13C NMR δ 16.8 (CH3), 26.4, 26.6, 26.7, 27.9,
29.9 (5 × CH2), 33.5 (CH2), 42.3 (CH3), 43.2 (CH), 55.0 (CH),
55.3 (CH2), 55.9 (CH), 63.1 (CH2) (diastereomer 3R,8R, visible
peaks 16.9, 28.0, 29.8, 32.9, 43.0, 55.1, 55.6, 63.7); IR (neat) ν
3304 (NH), 2922, 2850, 2772, 1476, 1447, 1373, 1344, 1232, 1155;
[R]20 -74.2 (c 0.78, CHCl3); CIMS (200 eV, t-BuH) m/z 374
D
(MH+, 100), 360 (4), 318 (3), 275 (MH+ - C6H12N, 4), 219 (MH+
- t-Bu - C6H12N, 5), 188 (5), 154 (2), 98 (C6H12N, 35), 86
(C5H12N, 4); HRMS (m/z) [MH+] C22H36N3O2 requires 374.2816,
found 374.2826.
General Procedure for Reduction of the Boc Group. A sol-
ution of N-(tert-butoxycarbonyl)-3-(S)-aminopyrrolidine 9-14 (2.00
mmol, 1.0 equiv) in dry THF (60 mL) was added over a 30-min
period to a suspension of lithium aluminum hydride (LiAlH4, 0.42 g,
11.0 mmol, 5.5 equiv) in freshly distilled THF (20 mL), placed
under an argon atmosphere at 0 °C. The solution was stirred at
room temperature for 5 h then heated at 60 °C for 1 h. After cooling
at 0 °C, the excess of LiAlH4 was hydrolyzed by successive addition
of cold water (1.2 mL), 4 M aqueous sodium hydroxide (1.2 mL),
and cold water (1.6 mL). The white precipitate was filtered on celite
and washed with CH2Cl2 (20 mL). The filtrate was concentrated,
and the residue was dissolved in Et2O (20 mL). Aqueous hydro-
chloric acid (1 M, 20 mL) was added and the solution was stirred
at room temperature for 15 min. The acidic aqueous layer was
extracted and NaHCO3 was slowly added until pH 9. The medium
was then extracted with CH2Cl2 (3 × 20 mL). The organic layers
were combined, dried (MgSO4), and concentrated under reduced
pressure.
[R]20 -24.0 (c 0.80, CHCl3); EIMS (70 eV) m/z 210 (M+, 6),
D
166 (5), 127 (M+ - C6H11, 56), 126 (C8H16N, 46), 93 (23), 82
(60), 70 (22), 58 (100).
N-Methyl-3-(S)-(2-(R)-(3,3-dimethylbutyl))aminopyrroli-
dine 18. Reduction of N-(tert-butoxycarbonyl)-3-(S)-(2-(R)-(3,3-
dimethylbutyl))aminopyrrolidine 12 (0.54 g, 2.00 mmol) following
5404 J. Org. Chem. Vol. 73, No. 14, 2008